These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 232737

  • 1. [Urinary excretion of cAMP after PTH injection in patients with hypohyperparathyroidism (author's transl)].
    González Macías J, Gertner JM, Brenton DB.
    Med Clin (Barc); 1979 Oct 10; 73(6):219-21. PubMed ID: 232737
    [Abstract] [Full Text] [Related]

  • 2. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W.
    Wien Klin Wochenschr Suppl; 1975 Oct 10; 33():1-15. PubMed ID: 176830
    [Abstract] [Full Text] [Related]

  • 3. [Investigations of the urinary cAMP-excretion in pseudohypoparathyroidism (author's transl)].
    Stögmann W.
    Padiatr Padol Suppl; 1977 Oct 10; (5):63-9. PubMed ID: 199875
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 10; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism.
    Coulson R, Moses AM.
    J Pharmacol Exp Ther; 1975 Sep 10; 194(3):603-13. PubMed ID: 169346
    [Abstract] [Full Text] [Related]

  • 6. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C, Galli M, Montagnani M, D'Amore I.
    Quad Sclavo Diagn; 1976 Mar 10; 12(1):15-38. PubMed ID: 190633
    [Abstract] [Full Text] [Related]

  • 7. [Investigation of cyclic renal adenosinmonophosphate (yamp)-excretion in pseudohypoparathyreoidism (author's transl)].
    Zabransky S.
    Klin Padiatr; 1975 May 10; 187(3):271-3. PubMed ID: 171472
    [Abstract] [Full Text] [Related]

  • 8. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP.
    Rubinger D, Wald H, Friedlaender MM, Silver J, Popovtzer MM.
    Miner Electrolyte Metab; 1988 May 10; 14(4):211-20. PubMed ID: 2850459
    [Abstract] [Full Text] [Related]

  • 9. Impaired parathyroid hormone action on urinary phosphorus excretion in isolated perfused kidney of streptozotocin-induced diabetic rats.
    Mokuda O, Sakamoto Y.
    Horm Metab Res; 1999 Oct 10; 31(10):543-5. PubMed ID: 10596962
    [Abstract] [Full Text] [Related]

  • 10. Pseudohypoparathyroidism showing positive phosphaturic and negative cyclic AMP excretion response to parathyroid hormone.
    Higashi K, Honda K, Morita M, Umeda T, Shimada T, Kimura K, Shido T, Arita I, Sato T.
    Endocrinol Jpn; 1989 Aug 10; 36(4):465-9. PubMed ID: 2555146
    [Abstract] [Full Text] [Related]

  • 11. Separation of pseudohypoparathyroidism into types I and II using only basal nephrogenous cAMP determinations.
    Singhellakis P, Pappas A, Nicolou CH, Ikkos D.
    Endocrinologie; 1991 Aug 10; 29(1-2):67-71. PubMed ID: 1666440
    [Abstract] [Full Text] [Related]

  • 12. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism.
    Mallette LE, Kirkland JL, Gagel RF, Law WM, Heath H.
    J Clin Endocrinol Metab; 1988 Nov 10; 67(5):964-72. PubMed ID: 2846629
    [Abstract] [Full Text] [Related]

  • 13. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)].
    Yamada K, Tamura Y, Yamamoto M, Kumagai A.
    Nihon Naibunpi Gakkai Zasshi; 1976 Oct 20; 52(10):983-96. PubMed ID: 190053
    [Abstract] [Full Text] [Related]

  • 14. Parathyroid hormone infusion test in children and adolescents.
    Hochberg Z, Moses AM, Richman RA.
    Miner Electrolyte Metab; 1984 Oct 20; 10(2):113-6. PubMed ID: 6321936
    [Abstract] [Full Text] [Related]

  • 15. [Case of pseudohypoparathyroidism type 1b diagnosed as having hypocalcemia].
    Iida S.
    Clin Calcium; 2005 Apr 20; 15(4):689-93. PubMed ID: 15802786
    [Abstract] [Full Text] [Related]

  • 16. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism.
    Breslau NA, Notman DD, Canterbury JM, Moses AM.
    Am J Med; 1980 Jun 20; 68(6):856-60. PubMed ID: 6247909
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of hypermagnesemia on the renal action of parathyroid hormone.
    Slatopolsky E, Mercado A, Morrison A, Yates J, Klahr S.
    J Clin Invest; 1976 Nov 20; 58(5):1273-9. PubMed ID: 186487
    [Abstract] [Full Text] [Related]

  • 18. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects].
    Fukami T, Fujita T, Yoshimoto Y, Fukase M, Imai Y, Sakaguchi K, Ogata E, Furukawa Y, Suzuki H, Takebe K.
    Nihon Naibunpi Gakkai Zasshi; 1984 Mar 20; 60(3):159-70. PubMed ID: 6090236
    [Abstract] [Full Text] [Related]

  • 19. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD, Herman RH.
    J Clin Endocrinol Metab; 1983 Jan 20; 56(1):11-7. PubMed ID: 6292254
    [Abstract] [Full Text] [Related]

  • 20. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.
    Kaminsky NI, Broadus AE, Hardman JG, Jones DJ, Ball JH, Sutherland EW, Liddle GW.
    J Clin Invest; 1970 Dec 20; 49(12):2387-95. PubMed ID: 5480862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.